Constellation Asset Advisors News
Constellation Asset Advisors, Inc. Forms Strategic Partnership With MD Capital Advisors, Inc.03/01/2011 | Press Release
Accelerates Development Of Emerging Healthcare Companies Globally
LAS VEGAS, March 1, 2011 -- Constellation Asset Advisors, Inc. ("CAA") today began a strategic partnership with MD Capital Advisors, Inc. ("MD Capital"). The agreement was formed to accelerate the development of dynamic emerging healthcare companies.
The announcement represents the next step in CAA's planned development as a multi-faceted equity markets consulting firm for dynamic small to mid-sized growth companies. MD Capital brings decades of international healthcare consulting experience to CAA. MD Capital currently represents a diverse portfolio of emerging healthcare companies seeking access to public equity markets to raise capital and create a currency that can be leveraged for strategic acquisition and unique roll up opportunities.
"The partnership with MD Capital dramatically increases our network of resources for our existing clients and partners," statedJens Dalsgaard, President of CAA. "I have personally travelled with the principals of MD Capital to Hong Kong and witnessed their skills and broad network they have created. Their access to industry leaders as well as exciting emerging healthcare companies has been demonstrated over the years. We look forward to working with MD Capital in the future and pooling our combined vast resources."
"The team at CAA has demonstrated a pattern of success and our healthcare clients will greatly benefit by working with Constellation," said Derek Cahill, principal of MD Capital. "Accessing capital through traditional venture capital (VCs), banks and private investment is no longer an option for most companies. The amount of control relinquished through private investment does not commensurate with the amount of capital invested."
About Constellation Asset Advisors, Inc.
Constellation Asset Advisors, Inc. ("CAA") is a multi-faceted equity markets consulting firm. The senior principals of CAA have been engaged in private equity since 1985, and have collectively over 50 years of Wall Street experience. CAA provides advisory services to dynamic small and mid-sized companies, as well as services to clients in the energy, specialty chemicals, high technology and healthcare sectors. CAA seeks to partner with publicly traded, fully reporting entities. It provides advisory services on acquisition and merger management, capital investment, turnarounds, and a myriad of other business transactions. CAA brings further value by using its multi-market experience and top-level strategic alliances to bring together unique, undervalued assets and the groups that can most efficiently capitalize on them. CAA maintains a strong emphasis on established, long term partnerships and business arrangements with the best companies and partners in their respective markets.
About MD Capital Advisors, Inc.
MD Capital Advisors, Inc. is a specialty healthcare advisory firm that assists business owners and management through the process of raising capital and growing their business through public entities. Our principals have raised hundreds of millions of dollars for companies and have hands on experience building companies, taking companies public, running public companies and managing the complicated financial affairs of multinational enterprises. We understand the challenges entrepreneurs face in achieving their dreams, we have been there. We compliment your management team and focus on reality based solutions that provide companies with the resources they need to reach their potential.
Safe Harbor Statement
This report includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2011 and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events. Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, the frequency, magnitude and timing of paper and other raw-material-price changes, general business and economic conditions beyond the Company's control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, and the Company's success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information since these statements may no longer be accurate or timely.
|For further contact:
For further contact:
For Media and Public Relations:
« back to news page
Testimonials"Teamwork, dedication, huge energy and confidence are in abundant supply at the Constellation Asset Management - their team is integral to all sectors of our business development from the Public Relations side to building and creating networking opportunities that lead to our expansion and growth. All of us at Ampio Pharma are grateful to Jens Dalsgaard and his excellent team for their support and their continued optimism with our business. Jens has a motto - "Whatever I can do to help this company grow and expand - I will do it and do it quickly." - and we see evidence of that motto every day. "
Donald B. Wingerter, CEO & Director, Ampio PharmaceuticalsSee all Testimonials